TMEM150B
Modulator of macroautophagy TMEM150B
Also known as: DRAM3, T150B_HUMAN, TMEM224, TTN2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NC51
- Gene
- TMEM150B
- Ensembl
- ENSG00000180061
- Chromosome
- 19
- Canonical length
- 233 aa
- Protein class
- Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a protein that belongs to the DRAM (damage-regulated autophagy modulator) family of membrane-spanning proteins. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
233 residues, UniProt reviewed canonical sequence.
>A6NC51|TMEM150B
1 MWGYLSLMPV FLAVWAISGV WIVFAIAVTN RTVDLSKGFP YISICGSFPP QSCIFSQVLN
61 MGAALAAWIC IVRYHQLRDW GVRRWPNQLI LWTGLLCALG TSVVGNFQEK NQRPTHLAGA
121 FLAFILGNVY FWLQLLLWRL KRLPQPGAAW IGPLRLGLCS VCTILIVAMI VLHACSLRSV
181 SAACEWVVAM LLFALFGLLA VDFSALESCT LCVQPWPSLS PPPASPISLP VQLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TMEM150B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 6
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 60 nTPM
Expression across tissuesHPA
Tissue
- duodenum: 60 nTPM
- small intestine: 54 nTPM
- lung: 11 nTPM
- colon: 9.6 nTPM
- rectum: 6.8 nTPM
- appendix: 5.5 nTPM
Single-cell type
- enterocytes: 107 nCPM
- proximal tubule cells: 28 nCPM
- kupffer cells: 20 nCPM
- colonocytes: 17 nCPM
- monocytes: 17 nCPM
- goblet cells: 13 nCPM
Immune cell
- classical monocyte: 5.7 nTPM
- basophil: 1.9 nTPM
- intermediate monocyte: 1.1 nTPM
- total PBMC: 0.8 nTPM
- myeloid DC: 0.5 nTPM
- non-classical monocyte: 0.3 nTPM
Brain region
- thalamus: 6.4 nTPM
- pons: 2.6 nTPM
- medulla oblongata: 2 nTPM
- choroid plexus: 1.8 nTPM
- white matter: 1.8 nTPM
- cerebral cortex: 1.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.72
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.27
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TMEM150B as an antibody target. Whether an autoantibody or antibody against TMEM150B could matter depends on whether native TMEM150B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TMEM150B is annotated at the cell surface, where native TMEM150B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TMEM150B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...